Genetics CME

Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Molecular Testing for EGFR Mutations in the Context of a Changing Treatment Landscape, Evolving Testing Options, and New Guidelines: What Pathologists Need to Know and Do
Lynette Sholl, MD
11 December, 2018
Credits: 0.50 CME
Medical Learning Institute, Inc.
Expert Insights on Available and Emerging Therapies for the Management of Pompe Disease
Loren del Mar Pena, MD, PhD
8 November, 2018
Credits: 2.00 CME
Medical Learning Institute, Inc.
Realizing the Potential of Precision Oncology in Lung Cancer—Challenges and Opportunities: Strengthening the Partnership Between Oncology and Pathology to Make the Most of the Latest Diagnostics and Therapies
Edward Garon, MD, MS
5 July, 2018
Credits: 1.50 CME
Medical Learning Institute, Inc.
The Evolving Role of Current and Novel Therapies in Improving Outcomes in Adults With PKU
14 June, 2018
Credits: 0.50 CME
Medical Learning Institute, Inc.
Diagnosing and Treating Acid Sphingomyelinase Deficiency: The Potential Impact of New Consensus Recommendations and Ongoing Clinical Trials of Emerging Therapies
Robin Lachmann, MD, PhD
25 May, 2018
Credits: 0.50 CME
Medical Learning Institute, Inc.
A Patient’s Journey From Diagnosis to Treatment: A Story on the Transformative Impact of Precision Medicine on Spinal Muscular Atrophy Management
Nancy Kuntz, MD
16 March, 2018
Credits: 0.25 CME
Medical Learning Institute, Inc.
Recognizing and Treating Lysosomal Storage Diseases: Expert Thoughts for the Pediatrician and General Practitioner
William Wilcox, MD, PhD
13 March, 2018
Credits: 0.50 CME / CE
Medical Learning Institute, Inc.
Navigating Diagnostics and the Management of Growth Hormone Deficiency in Children and Adults
Andrew Dauber, MD, MMSc
8 March, 2018
Credits: 1.50 CME
Medical Learning Institute, Inc.
Moving in Leaps and Bounds Towards Precision Immuno-Oncology: Latest Biomarker Strategies to Guide Patient Selection and Maximize the Potential of Cancer Immunotherapies
Naiyer Rizvi, MD
2 March, 2018